Risk factors
ENDRA Life Sciences (NDRA) risk factors
Item 1A of every ENDRA Life Sciences Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors64 risks
TAEUS commercialization depends on regulatory clearances, market adoption, reimbursement, and building sales and distribution capabilities.
Filed Mar 31, 2026